Boothwyn, Pennsylvania

Investment Date:
June 2012

Exit Date:
October 2021

Pentec Health

An industry leader for more than 30 years, Pentec Health provides patient-specific compounded sterile medications for administration in dialysis centers, as well as provides in-home Specialty Infusion services and complex pharmaceutical products to patients who require access outside of a hospital setting.

Pentec was named one of the fastest growing companies in the Philadelphia region for 7th year in a row as part of the 2017 Philadelphia 100® Awards. In 2018, Pentec also made the Inc. 5000 List for the 9th year in a row.

NEP sold Pentec Health to Wellspring Capital in October 2021.